Search research articles
Contact Us
Filters
Showing results (241-250 of 277) with videos related to
Page
of 28
Sort By:
Cancer Research
|
February 11, 2010
The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3
Christopher P Guise, Maria R Abbattista, Rachelle S Singleton, et al.
Cancer Gene Therapy
|
February 9, 2021
Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours
Alexandra M Mowday, Ludwig J Dubois, Aleksandra M Kubiak, et al.
Chest
|
May 22, 2021
Response
Evan J Zasowski, Matteo Bassetti, Francesco Blasi, et al.
Journal of the American Heart Association
|
August 1, 2019
Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
Mina Owlia, John A Dodson, Jordan B King, et al.
JCO Clinical Cancer Informatics
|
September 27, 2021
Ascertainment of Veterans With Metastatic Prostate Cancer in Electronic Health Records: Demonstrating the Case for Natural Language Processing
Patrick R Alba, Anthony Gao, Kyung Min Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Adam V Patterson, Dianne M Ferry, Shelley J Edmunds, et al.
Journal of Medicinal Chemistry
|
September 8, 2025
Design, Synthesis and Biological Evaluation of 7-(1-Methyl-1<i>H</i>-indole-3-yl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine Derivatives as Novel Covalent pan-FGFR Inhibitors to Overcome Clinical Resistance
Wuqing Deng, Xiaojuan Chen, Ling Yan, et al.
Molecules (Basel, Switzerland)
|
October 27, 2020
Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
Chris P Guise, Maria R Abbattista, Robert F Anderson, et al.
Journal of Medicinal Chemistry
|
September 29, 2022
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells
Fang Xu, Xin Zhang, Zhipeng Chen, et al.
Circulation. Cardiovascular Interventions
|
February 18, 2022
Ankle- and Toe-Brachial Index for Peripheral Artery Disease Identification: Unlocking Clinical Data Through Novel Methods
Julia E Friberg, Abdul H Qazi, Brenden Boyle, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 277) with videos related to
Sort By:
Page
of 28
Cancer Research
|
February 11, 2010
The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3
Christopher P Guise, Maria R Abbattista, Rachelle S Singleton, et al.
Cancer Gene Therapy
|
February 9, 2021
Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours
Alexandra M Mowday, Ludwig J Dubois, Aleksandra M Kubiak, et al.
Chest
|
May 22, 2021
Response
Evan J Zasowski, Matteo Bassetti, Francesco Blasi, et al.
Journal of the American Heart Association
|
August 1, 2019
Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
Mina Owlia, John A Dodson, Jordan B King, et al.
JCO Clinical Cancer Informatics
|
September 27, 2021
Ascertainment of Veterans With Metastatic Prostate Cancer in Electronic Health Records: Demonstrating the Case for Natural Language Processing
Patrick R Alba, Anthony Gao, Kyung Min Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Adam V Patterson, Dianne M Ferry, Shelley J Edmunds, et al.
Journal of Medicinal Chemistry
|
September 8, 2025
Design, Synthesis and Biological Evaluation of 7-(1-Methyl-1<i>H</i>-indole-3-yl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine Derivatives as Novel Covalent pan-FGFR Inhibitors to Overcome Clinical Resistance
Wuqing Deng, Xiaojuan Chen, Ling Yan, et al.
Molecules (Basel, Switzerland)
|
October 27, 2020
Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
Chris P Guise, Maria R Abbattista, Robert F Anderson, et al.
Journal of Medicinal Chemistry
|
September 29, 2022
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells
Fang Xu, Xin Zhang, Zhipeng Chen, et al.
Circulation. Cardiovascular Interventions
|
February 18, 2022
Ankle- and Toe-Brachial Index for Peripheral Artery Disease Identification: Unlocking Clinical Data Through Novel Methods
Julia E Friberg, Abdul H Qazi, Brenden Boyle, et al.
Page
of 28